Mir A. Imran - 23 Oct 2025 Form 4 Insider Report for Rani Therapeutics Holdings, Inc. (RANI)

Reporting relationship: Director, 10%+ Owner
Issuer ticker: RANI
Reported as of: 23 Oct 2025
Net transaction value: +$1,260,417
SEC form: 4
Accepted by SEC: 27 Oct 2025, 19:24:25 UTC
Prior SEC filing: 30 May 2025
Next SEC filing: 01 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Svai Sanford, Attorney-in-Fact for Mir A Imran

Key filing fact

Mir A. Imran filed Form 4 for Rani Therapeutics Holdings, Inc. (RANI) on 27 Oct 2025.

Key facts

This page summarizes Mir A. Imran's Form 4 filing for Rani Therapeutics Holdings, Inc. (RANI).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 27 Oct 2025, 19:24.

Change

Previous filing in this sequence was filed on 30 May 2025.
Current net transaction value: +$1,260,417.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001031686 Primary reporting owner

IMRAN MIR A

Relationship: Director, 10%+ Owner
Address: C/O RANI THERAPEUTICS LLC, 2051 RINGWOOD AVE., SAN JOSE
Signature: /s/ Svai Sanford, Attorney-in-Fact for Mir A Imran
Signature date: 27 Oct 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RANI transaction

Class A Common Stock

Purchase

Transaction value: $1,260,417
Shares: +2,083,334
Change %
Price: $0.6050
Shares after: 2,083,334
Date: 23 Oct 2025
Ownership: Direct
Footnotes: F1

RANI holding

Class A Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 74,139
Date: 23 Oct 2025
Ownership: See footnote
Footnotes: F2

RANI holding

Class B Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 22,660,053
Date: 23 Oct 2025
Ownership: See Footnote
Footnotes: F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RANI transaction Derivative

Warrant to Purchase Class A Common Stock

Purchase

Transaction value: $0
Shares: +2,083,334
Change %
Price: $0.000000
Shares after: 2,083,334
Date: 23 Oct 2025
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 2,083,334
Exercise price: $0.4800
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The Reporting Person purchased these shares in a PIPE offering conducted by the Issuer.

Footnote F2

The Reporting Person is a General Partner of InCube Ventures II, L.P. and Rani Investment Corp. InCube Labs, L.L.C. is wholly-owned by the Reporting Person and his family. Represents 52,781 shares of Class A Common Stock of the Issuer held by InCube Ventures II, L.P., 13,664 shares of Class A Common Stock of the Issuer held by InCube Labs, L.L.C., and 7,694 Class A Shares held by Rani Investment Corp. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Footnote F3

The Reporting Person is a General Partner of InCube Ventures II, L.P., and InCube Labs, LLC is wholly-owned by the Reporting Person and his family. Represents 22,411,124 Class B Shares held by InCube Labs, LLC and 248,929 Class B Shares held by InCube Ventures II, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Footnote F4

The warrants shall be exercisable upon stockholder approval and have a term of exercise equal to five years from the date of such stockholder approval.